Advertisement
Screener

DAVITA INC. (DVA) Payments of Financing Costs

2.0 / 5 stars · 43/110 Roast Me

DAVITA INC. Payments of Financing Costs

DAVITA INC. (DVA) reported Payments of Financing Costs of $4.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsOfFinancingCosts · last filed 2026-08-04

  • DAVITA INC. payments of financing costs for the quarter ending 2026-06-30 was $1.76M, a 90.58% decline year-over-year.
  • DAVITA INC. payments of financing costs for the quarter ending 2026-03-31 was $2.88M, a 55.05% decline year-over-year.
  • DAVITA INC. payments of financing costs for the quarter ending 2025-12-31 was $27.40M, a 463.50% increase year-over-year.
  • DAVITA INC. payments of financing costs for the quarter ending 2025-09-30 was $1.28M, a 95.07% decline year-over-year.
  • DAVITA INC. payments of financing costs for fiscal 2025 was $53.82M, a 5.79% increase from fiscal 2024.
  • DAVITA INC. payments of financing costs for fiscal 2024 was $50.87M, a 27.11% decline from fiscal 2023.
  • DAVITA INC. payments of financing costs for fiscal 2023 was $69.79M.
  • DAVITA INC. payments of financing costs for fiscal 2016 was $188.00K, a 99.75% decline from fiscal 2015.
Period endPayments of Financing Costs 3 monthPayments of Financing Costs 6 monthPayments of Financing Costs 9 monthPayments of Financing Costs 12 month
2026-06-30$1.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$4.64M
10-Q · filed 2026-08-04
$32.05M
derived: sum of 3 quarters · filed 2026-08-04
$33.33M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$2.88M
10-Q · filed 2026-05-05
$30.29M
derived: sum of 2 quarters · filed 2026-05-05
$31.57M
derived: sum of 3 quarters · filed 2026-05-05
$50.29M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$27.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$28.69M
derived: sum of 2 quarters · filed 2026-02-11
$47.41M
derived: sum of 3 quarters · filed 2026-08-04
$53.82M
10-K · filed 2026-02-11
2025-09-30$1.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
$20.00M
derived: sum of 2 quarters · filed 2026-08-04
$26.42M
10-Q · filed 2025-10-29
$31.28M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30$18.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$25.13M
10-Q · filed 2026-08-04
$30.00M
derived: sum of 3 quarters · filed 2026-08-04
$56.01M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$6.41M
10-Q · filed 2026-05-05
$11.27M
derived: sum of 2 quarters · filed 2026-05-05
$37.29M
derived: sum of 3 quarters · filed 2026-05-05
$57.19M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$4.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$30.88M
derived: sum of 2 quarters · filed 2026-02-11
$50.77M
derived: sum of 3 quarters · filed 2026-02-11
$50.87M
10-K · filed 2026-02-11
2024-09-30$26.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
$45.91M
derived: sum of 2 quarters · filed 2025-10-29
$46.01M
10-Q · filed 2025-10-29
$62.34M
derived: sum of 4 quarters · filed 2026-02-11
2024-06-30$19.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$19.99M
10-Q · filed 2025-08-05
$36.32M
derived: sum of 3 quarters · filed 2026-02-11
$44.77M
derived: sum of 4 quarters · filed 2026-02-11
2024-03-31$99.00K
10-Q · filed 2025-05-12
$16.42M
derived: sum of 2 quarters · filed 2026-02-11
$24.88M
derived: sum of 3 quarters · filed 2026-02-11
$69.88M
derived: sum of 4 quarters · filed 2026-02-11
2023-12-31$16.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$24.78M
derived: sum of 2 quarters · filed 2026-02-11
$69.78M
derived: sum of 3 quarters · filed 2026-02-11
$69.79M
10-K · filed 2026-02-11
2023-09-30$8.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
$53.46M
derived: sum of 2 quarters · filed 2024-10-29
$53.47M
10-Q · filed 2024-10-29
2023-06-30$45.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$45.01M
10-Q · filed 2024-08-06
2023-03-31$7.00K
10-Q · filed 2024-05-02
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$0.00
derived: sum of 2 quarters · filed 2023-11-07
$0.00
10-Q · filed 2023-11-07
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$0.00
10-Q · filed 2023-08-03
2022-03-31$0.00
10-Q · filed 2023-05-08
2021-09-30$2.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-31
$745.00K
derived: sum of 2 quarters · filed 2022-10-31
$9.09M
10-Q · filed 2022-10-31
2021-06-30$743.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01
$9.09M
10-Q · filed 2022-08-01
2021-03-31$8.35M
10-Q · filed 2022-05-05
2020-09-30$85.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28
$105.36M
derived: sum of 2 quarters · filed 2021-10-28
$105.70M
10-Q · filed 2021-10-28
2020-06-30$20.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03
$20.38M
10-Q · filed 2021-08-03
2020-03-31$350.00K
10-Q · filed 2021-04-29
2017-03-31$0.00
10-Q · filed 2017-05-02
$0.00
derived: sum of 2 quarters · filed 2017-05-02
$0.00
derived: sum of 3 quarters · filed 2017-05-02
$0.00
derived: sum of 4 quarters · filed 2017-05-02
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$0.00
derived: sum of 2 quarters · filed 2017-02-24
$0.00
derived: sum of 3 quarters · filed 2017-02-24
$188.00K
10-K · filed 2017-02-24
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$0.00
derived: sum of 2 quarters · filed 2016-11-02
$188.00K
10-Q · filed 2016-11-02
$17.51M
derived: sum of 4 quarters · filed 2017-05-02
2016-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$188.00K
10-Q · filed 2016-08-08
$17.51M
derived: sum of 3 quarters · filed 2017-05-02
$18.32M
derived: sum of 4 quarters · filed 2017-05-02
2016-03-31$188.00K
10-Q · filed 2017-05-02
$17.51M
derived: sum of 2 quarters · filed 2017-05-02
$18.32M
derived: sum of 3 quarters · filed 2017-05-02
2015-12-31$17.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$18.13M
derived: sum of 2 quarters · filed 2017-02-24
$76.67M
10-K · filed 2017-02-24
2015-09-30$815.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$59.35M
10-Q · filed 2016-11-02
2015-06-30$58.54M
10-Q · filed 2016-08-08
2014-12-31$834.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$16.05M
derived: sum of 2 quarters · filed 2017-02-24
$122.99M
10-K · filed 2017-02-24
2014-09-30$15.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$122.15M
10-Q · filed 2015-11-05
2014-06-30$106.94M
10-Q · filed 2015-08-05
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$3.00K
derived: sum of 2 quarters · filed 2016-02-26
$719.00K
10-K · filed 2016-02-26
2013-09-30$3.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$719.00K
10-Q · filed 2014-11-06
2013-06-30$716.00K
10-Q · filed 2014-08-01
2012-12-31$57.24M
10-K · filed 2015-02-26
2011-12-31$17.86M
10-K · filed 2013-03-01
2010-12-31$113.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01
$113.81M
10-K · filed 2013-03-01
2010-09-30$46.00K
10-Q · filed 2010-11-05
2009-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2010-02-25
$0.00
derived: sum of 2 quarters · filed 2010-11-05
$42.00K
10-K · filed 2010-02-25
2009-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05
$42.00K
10-Q · filed 2010-11-05
2009-06-30$42.00K
10-Q · filed 2010-08-05
2008-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2010-02-25
$0.00
derived: sum of 2 quarters · filed 2010-02-25
$130.00K
10-K · filed 2010-02-25
2008-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05
$130.00K
10-Q · filed 2009-11-05
2008-06-30$130.00K
10-Q · filed 2009-08-07
2007-12-31$4.51M
10-K · filed 2010-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sotera Health Co (SHC)United States$5.271B30.96
Progyny, Inc. (PGNY)United States$1.994B28.37
agilon health, inc. (AGL)United States$1.272B-7.76
VIEMED HEALTHCARE, INC. (VMD)United States$0.336B29.92
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43